Cortical Tubers: Windows into Dysregulation of Epilepsy Risk and Synaptic Signaling Genes by MicroRNAs

Cerebral Cortex

Volumn 26, Issue 3, 2016, Pages 1059-1071

  Dombkowski, Alan A ^a   Batista, Carlos E ^a   Cukovic, Daniela ^a   Carruthers, Nicholas J ^c   Ranganathan, Ramya ^a   Shukla, Upasana ^a   Stemmer, Paul M ^c   Chugani, Harry T ^a,b   Chugani, Diane C ^a  

^a CHILDREN'S HOSPITAL OF MICHIGAN   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WAYNE STATE UNIVERSITY   (United States)

Author keywords

Expression profiling; hamartin; proteomics; synapse; tuberous sclerosis complex

Indexed keywords

HAMARTIN; MICRORNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN P53; PROTEOME; TUBEROUS SCLEROSIS COMPLEX 1 PROTEIN; TUMOR SUPPRESSOR PROTEIN;

3' UNTRANSLATED REGION; ARTICLE; CHILD; EPILEPSY; FEMALE; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; LIQUID CHROMATOGRAPHY; MALE; PRIORITY JOURNAL; PROTEOMICS; SIGNAL TRANSDUCTION; SYNAPSE; TANDEM MASS SPECTROMETRY; TUBEROUS SCLEROSIS; BRAIN; COMPLICATION; DRUG RESISTANT EPILEPSY; GENETICS; METABOLISM; MICROARRAY ANALYSIS; PRESCHOOL CHILD; REAL TIME POLYMERASE CHAIN REACTION; RISK;

BRAIN; CHILD; CHILD, PRESCHOOL; CHROMATOGRAPHY, LIQUID; DRUG RESISTANT EPILEPSY; FEMALE; HUMANS; MALE; MICROARRAY ANALYSIS; MICRORNAS; NF-KAPPA B; PROTEOME; REAL-TIME POLYMERASE CHAIN REACTION; RISK; SYNAPSES; TANDEM MASS SPECTROMETRY; TUBEROUS SCLEROSIS; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 84961267120     PISSN: 10473211     EISSN: 14602199     Source Type: Journal    
DOI: 10.1093/cercor/bhu276     Document Type: Article

References (80)

1. Aebersold R, Burlingame AL, Bradshaw RA. 2013. Western blots versus selected reaction monitoring assays: time to turn the tables Mol Cell Proteomics. 12:2381-2382.
2. Agostini M, Tucci P, Steinert JR, Shalom-Feuerstein R, Rouleau M, Aberdam D, Forsythe ID, Young KW, Ventura A, Concepcion CP, et al. 2011. microRNA-34a regulates neurite outgrowth, spinal morphology, and function. Proc Natl Acad Sci USA. 108:21099-21104.
3. Aranha MM, Santos DM, Sola S, Steer CJ, Rodrigues CM. 2011. miR-34a regulates mouse neural stem cell differentiation. PLoS One. 6:e21396.
4. Aranha MM, Santos DM, Xavier JM, Low WC, Steer CJ, Sola S, Rodrigues CM. 2010. Apoptosis-associated microRNAs are modulated in mouse, rat and human neural differentiation. BMC Genomics. 11:514.
5. Aronica E, Crino PB. 2011. Inflammation in epilepsy: clinical observations. Epilepsia. 52(Suppl 3):26-32.
6. Boer K, Crino PB, Gorter JA, Nellist M, Jansen FE, Spliet WG, van Rijen PC, Wittink FR, Breit TM, Troost D, et al. 2010. Gene expression analysis of tuberous sclerosis complex cortical tubers reveals increased expression of adhesion and inflammatory factors. Brain Pathol. 20:704-719.
7. Boer K, Troost D, Jansen F, Nellist M, van den Ouweland AM, Geurts JJ, Spliet WG, Crino P, Aronica E. 2008. Clinicopathological and immunohistochemical findings in an autopsy case of tuberous sclerosis complex. Neuropathology. 28:577-590.
8. Boon RA, Iekushi K, Lechner S, Seeger T, Fischer A, Heydt S, Kaluza D, Treguer K, Carmona G, Bonauer A, et al. 2013. Micro-RNA-34a regulates cardiac ageing and function. Nature. 495: 107-110.
9. Chang TC, Wentzel EA, Kent OA, Ramachandran K, MullendoreM, Lee KH, Feldmann G, Yamakuchi M, Ferlito M, Lowenstein CJ, et al. 2007. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell. 26:745-752.
10. Chugani HT, Luat AF, Kumar A, Govindan R, Pawlik K, Asano E. 2013. alpha-[11C]-Methyl-L-tryptophan-PET in 191 patients with tuberous sclerosis complex. Neurology. 81:674-680.
11. Crino PB, Aronica E, Baltuch G, Nathanson KL. 2010. Biallelic TSC gene inactivation in tuberous sclerosis complex. Neurology. 74:1716-1723.
12. Dombkowski AA, Sultana Z, Craig DB, Jamil H. 2011. In silico analysis of combinatorial microRNA activity reveals target genes and pathways associated with breast cancer metastasis. Cancer Inform. 10:13-29.
13. Dweep H, Sticht C, Pandey P, Gretz N. 2011. miRWalk-database: prediction of possible miRNA binding sites by "walking" the genes of three genomes. J Biomed Inform. 44:839-847.
14. FilipowiczW, Bhattacharyya SN, Sonenberg N. 2008. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight Nat Rev Genet. 9:102-114.
15. Fineberg SK, Datta P, Stein CS, Davidson BL. 2012. MiR-34a represses Numbl in murine neural progenitor cells and antagonizes neuronal differentiation. PLoS One. 7:e38562.
16. Fineberg SK, Kosik KS, Davidson BL. 2009. MicroRNAs potentiate neural development. Neuron. 64:303-309.
17. Gao J, Liu QG. 2011. The role of miR-26 in tumors and normal tissues (Review). Oncol Lett. 2:1019-1023.
18. Gleeson JG, Allen KM, Fox JW, Lamperti ED, Berkovic S, Scheffer I, Cooper EC, Dobyns WB, Minnerath SR, Ross ME, et al. 1998. Doublecortin, a brain-specific gene mutated in human Xlinked lissencephaly and double cortex syndrome, encodes a putative signaling protein. Cell. 92:63-72.
19. Hackstadt AJ, Hess AM. 2009. Filtering for increased power for microarray data analysis. BMC Bioinformatics. 10:11.
20. He L, He X, Lim LP, de Stanchina E, Xuan Z, Liang Y, Xue W, Zender L, Magnus J, Ridzon D, et al. 2007. A microRNA component of the p53 tumour suppressor network. Nature. 447: 1130-1134.
21. Homanics GE, DeLorey TM, Firestone LL, Quinlan JJ, Handforth A, Harrison NL, Krasowski MD, Rick CE, Korpi ER, Makela R, et al. 1997. Mice devoid of gamma-aminobutyrate type A receptor beta3 subunit have epilepsy, cleft palate, and hypersensitive behavior. Proc Natl Acad Sci USA. 94:4143-4148.
22. Hu K, Xie YY, Zhang C, Ouyang DS, Long HY, Sun DN, Long LL, Feng L, Li Y, Xiao B. 2012. MicroRNA expression profile of the hippocampus in a rat model of temporal lobe epilepsy and miR-34a-targeted neuroprotection against hippocampal neurone cell apoptosis post-status epilepticus. BMC Neurosci. 13:115.
23. Hu K, Zhang C, Long L, Long X, Feng L, Li Y, Xiao B. 2011. Expression profile of microRNAs in rat hippocampus following lithium-pilocarpine-induced status epilepticus. Neurosci Lett. 488:252-257.
24. Huang daW, Sherman BT, Lempicki RA. 2009. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 4:44-57.
25. Jimenez-Mateos EM, Engel T, Merino-Serrais P, McKiernan RC, Tanaka K, Mouri G, Sano T, O'Tuathaigh C, Waddington JL, Prenter S, et al. 2012. Silencing microRNA-134 produces neuroprotective and prolonged seizure-suppressive effects. Nat Med. 18:1087-1094.
26. Jozwiak S, Kwiatkowski D, Kotulska K, Larysz-Brysz M, Lewin-Kowalik J, Grajkowska W, Roszkowski M. 2004. Tuberin and hamartin expression is reduced in the majority of subependymal giant cell astrocytomas in tuberous sclerosis complex consistent with a two-hit model of pathogenesis. J Child Neurol. 19:102-106.
27. Junker A, Krumbholz M, Eisele S, Mohan H, Augstein F, Bittner R, Lassmann H, Wekerle H, Hohlfeld R, Meinl E. 2009. MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47. Brain. 132:3342-3352.
28. Kerfoot C, Wienecke R, Menchine M, Emelin J, Maize JC Jr, Welsh CT, Norman MG, DeClue JE, Vinters HV. 1996. Localization of tuberous sclerosis 2 mRNA and its protein product tuberin in normal human brain and in cerebral lesions of patients with tuberous sclerosis. Brain Pathol. 6:367-375.
29. Kim AH, Reimers M, Maher B, Williamson V, McMichael O, McClay JL, van den Oord EJ, Riley BP, Kendler KS, Vladimirov VI. 2010. MicroRNA expression profiling in the prefrontal cortex of individuals affected with schizophrenia and bipolar disorders. Schizophrenia Res. 124:183-191.
30. Krichevsky AM, King KS, Donahue CP, Khrapko K, Kosik KS. 2003. A microRNA array reveals extensive regulation of microRNAs during brain development. RNA. 9:1274-1281.
31. Krzesniak M, Zajkowicz A, Matuszczyk I, Rusin M. 2014. Rapamycin prevents strong phosphorylation of p53 on serine 46 and attenuates activation of the p53 pathway in A549 lung cancer cells exposed to actinomycin D. Mech Ageing Dev. 139:11-21.
32. Kuhn DE, Martin MM, Feldman DS, Terry AV Jr, Nuovo GJ, Elton TS. 2008. Experimental validation of miRNA targets. Methods. 44:47-54.
33. Lai CY, Yu SL, Hsieh MH, Chen CH, Chen HY, Wen CC, Huang YH, Hsiao PC, Hsiao CK, Liu CM, et al. 2011. MicroRNA expression aberration as potential peripheral blood biomarkers for schizophrenia. PLoS One. 6:e21635.
34. Lee CH, Inoki K, Karbowniczek M, Petroulakis E, Sonenberg N, Henske EP, Guan KL. 2007. Constitutive mTOR activation in TSC mutants sensitizes cells to energy starvation and genomic damage via p53. EMBO J. 26:4812-4823.
35. Li C, Xiong Q, Zhang J, Ge F, Bi LJ. 2012. Quantitative proteomic strategies for the identification of microRNA targets. Expert Rev Proteomics. 9:549-559.
36. Li X, Khanna A, Li N, Wang E. 2011. Circulatory miR34a as an RNA based, noninvasive biomarker for brain aging. Aging. 3:985-1002.
37. Liu Q, Halvey PJ, Shyr Y, Slebos RJ, Liebler DC, Zhang B. 2013. Integrative omics analysis reveals the importance and scope of translational repression in microRNA-mediated regulation. Mol Cell Proteomics. 12:1900-1911.
38. Maldonado M, Baybis M, Newman D, Kolson DL, Chen W, McKhann G 2nd, Gutmann DH, Crino PB. 2003. Expression of ICAM-1, TNF-alpha, NF kappa B, and MAP kinase in tubers of the tuberous sclerosis complex. Neurobiol Dis. 14:279-290.
39. McAlister GC, Huttlin EL, Haas W, Ting L, Jedrychowski MP, Rogers JC, Kuhn K, Pike I, Grothe RA, Blethrow JD, et al. 2012. Increasing the multiplexing capacity of TMTs using reporter ion isotopologues with isobaric masses. Anal Chem. 84: 7469-7478.
40. Michalski A, Cox J, Mann M. 2011. More than 100,000 detectable peptide species elute in single shotgun proteomics runs but the majority is inaccessible to data-dependent LC-MS/MS. J Proteome Res. 10:1785-1793.
41. Mizuguchi M, Ikeda K, Takashima S. 2000. Simultaneous loss of hamartin and tuberin from the cerebrum, kidney and heart with tuberous sclerosis. Acta Neuropathol. 99:503-510.
42. Mizuguchi M, Kato M, Yamanouchi H, Ikeda K, Takashima S. 1996. Loss of tuberin from cerebral tissues with tuberous sclerosis and astrocytoma. Ann Neurol. 40:941-944.
43. Mizuguchi M, Kato M, YamanouchiH, Ikeda K, Takashima S. 1997.Tuberin immunohistochemistry in brain, kidneys and heart with or without tuberous sclerosis. Acta Neuropathol. 94:525-531.
44. Mizuguchi M, Takashima S. 2001. Neuropathology of tuberous sclerosis. Brain Dev. 23:508-515.
45. Morgado AL, Xavier JM, Dionisio PA, Ribeiro MF, Dias RB, Sebastiao AM, Sola S, Rodrigues CM. 2014. MicroRNA-34a modulates neural stem cell differentiation by regulating expression of synaptic and autophagic proteins. Mol Neurobiol.
46. Nagaraj N, Wisniewski JR, Geiger T, Cox J, Kircher M, Kelso J, Paabo S, Mann M. 2011. Deep proteome and transcriptome mapping of a human cancer cell line. Mol Syst Biol. 7:548.
47. Nielsen JA, Lau P, Maric D, Barker JL, Hudson LD. 2009. Integrating microRNA and mRNA expression profiles of neuronal progenitors to identify regulatory networks underlying the onset of cortical neurogenesis. BMC Neurosci. 10:98.
48. Niida Y, Stemmer-Rachamimov AO, Logrip M, Tapon D, Perez R, Kwiatkowski DJ, Sims K, MacCollin M, Louis DN, Ramesh V. 2001. Survey of somatic mutations in tuberous sclerosis complex (TSC) hamartomas suggests different genetic mechanisms for pathogenesis of TSC lesions. Am J Hum Genet. 69:493-503.
49. Ostendorf AP, Gutmann DH, Weisenberg JL. 2013. Epilepsy in individualswith neurofibromatosis type 1. Epilepsia. 54:1810-1814.
50. Peng C, Li N, Ng YK, Zhang J, Meier F, Theis FJ, Merkenschlager M, Chen W, Wurst W, Prakash N. 2012. A unilateral negative feedback loop between miR-200 microRNAs and Sox2/E2F3 controls neural progenitor cell-cycle exit and differentiation. J Neurosci. 32:13292-13308.
51. Rao Y, Lee Y, Jarjoura D, Ruppert AS, Liu CG, Hsu JC, Hagan JP. 2008. A comparison of normalization techniques for micro-RNA microarray data. Stat Appl Genet Mol Biol. 7:Article22.
52. Raver-Shapira N, Marciano E, Meiri E, Spector Y, Rosenfeld N, Moskovits N, Bentwich Z, Oren M. 2007. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol Cell. 26:731-743.
53. Rehmsmeier M, Steffen P, Hochsmann M, Giegerich R. 2004. Fast and effective prediction of microRNA/target duplexes. RNA. 10:1507-1517.
54. Reyes-Herrera PH, Ficarra E. 2012. One decade of development and evolution of microRNA target prediction algorithms. Genomics Proteomics Bioinformatics. 10:254-263.
55. Riley T, Sontag E, Chen P, Levine A. 2008. Transcriptional control of human p53-regulated genes. Nat Rev Mol Cell Biol. 9:402-412.
56. Risbud RM, Porter BE. 2013. Changes in microRNA expression in the whole hippocampus and hippocampal synaptoneurosome fraction following pilocarpine induced status epilepticus. PLoS One. 8:e53464.
57. Roach ES, DiMario FJ, Kandt RS, Northrup H. 1999. Tuberous Sclerosis Consensus Conference: recommendations for diagnostic evaluation. National Tuberous Sclerosis Association. J Child Neurol. 14:401-407.
58. Roach ES, Sparagana SP. 2004. Diagnosis of tuberous sclerosis complex. J Child Neurol. 19:643-649.
59. Rokavec M, Li H, Jiang L, Hermeking H. 2014. The p53/miR-34 axis in development and disease. J Mol Cell Biol. 6:214-230.
60. Romaker D, Kumar V, Cerqueira DM, Cox RM, Wessely O. 2014. MicroRNAs are critical regulators of tuberous sclerosis complex and mTORC1 activity in the size control of the Xenopus kidney. Proc Natl Acad Sci USA. 111:6335-6340.
61. Rosahl TW, Spillane D, Missler M, Herz J, Selig DK, Wolff JR, Hammer RE, Malenka RC, Sudhof TC. 1995. Essential functions of synapsins I and II in synaptic vesicle regulation. Nature. 375:488-493.
62. Sano T, Reynolds JP, Jimenez-Mateos EM, Matsushima S, Taki W, Henshall DC. 2012. MicroRNA-34a upregulation during seizure-induced neuronal death. Cell Death Dis. 3: e287.
63. Selbach M, Schwanhausser B, Thierfelder N, Fang Z, Khanin R, Rajewsky N. 2008. Widespread changes in protein synthesis induced by microRNAs. Nature. 455:58-63.
64. Shin J, Pan H, Zhong XP. 2012. Regulation of mast cell survival and function by tuberous sclerosis complex 1. Blood. 119: 3306-3314.
65. Somel M, Guo S, Fu N, Yan Z, Hu HY, Xu Y, Yuan Y, Ning Z, Hu Y, Menzel C, et al. 2010. MicroRNA, mRNA, and protein expression link development and aging in human and macaque brain. Genome Res. 20:1207-1218.
66. Somel M, Liu X, Tang L, Yan Z, Hu H, Guo S, Jiang X, Zhang X, Xu G, Xie G, et al. 2011. MicroRNA-driven developmental remodeling in the brain distinguishes humans from other primates. PLoS Biol. 9:e1001214.
67. Song YJ, Tian XB, Zhang S, Zhang YX, Li X, Li D, Cheng Y, Zhang JN, Kang CS, Zhao W. 2011. Temporal lobe epilepsy induces differential expression of hippocampal miRNAs including let-7e and miR-23a/b. Brain Res. 1387:134-140.
68. Tak PP, Firestein GS. 2001. NF-kappaB: a key role in inflammatory diseases. J Clin Invest. 107:7-11.
69. Thiele EA. 2004. Managing epilepsy in tuberous sclerosis complex. J Child Neurol. 19:680-686.
70. Thounaojam MC, Kaushik DK, Basu A. 2013. MicroRNAs in the brain: it's regulatory role in neuroinflammation. Mol Neurobiol. 47:1034-1044.
71. Vaishnavi V, Manikandan M, Tiwary BK, Munirajan AK. 2013. Insights on the functional impact of microRNAs present in autism-associated copy number variants. PLoS One. 8: e56781.
72. Vinaitheerthan M, Wei J, Mizuguchi M, Greco A, Barness EG. 2004. Tuberous sclerosis: immunohistochemistry expression of tuberin and hamartin in a 31-week gestational fetus. Fetal Pediatr Pathol. 23:241-249.
73. Viprey VF, Corrias MV, Burchill SA. 2012. Identification of reference microRNAs and suitability of archived hemopoietic samples for robust microRNA expression profiling. Anal Biochem. 421:566-572.
74. Wang N, Zhu M, Tsao SW, Man K, Zhang Z, Feng Y. 2013. MiR-23amediated inhibition of topoisomerase 1 expression potentiates cell response to etoposide in human hepatocellular carcinoma. Mol Cancer. 12:119.
75. Wang N, Zhu M, Wang X, Tan HY, Tsao SW, Feng Y. 2014. Berberine-induced tumor suppressor p53 up-regulation gets involved in the regulatory network of MIR-23a in hepatocellular carcinoma. Biochim Biophys Acta. 1839:849-857.
76. Wang X, Liu P, Zhu H, Xu Y, Ma C, Dai X, Huang L, Liu Y, Zhang L, Qin C. 2009. miR-34a, a microRNA up-regulated in a double transgenic mouse model of Alzheimer's disease, inhibits bcl2 translation. Brain Res Bull. 80:268-273.
77. Weiner HL, Ferraris N, LaJoie J, Miles D, Devinsky O. 2004. Epilepsy surgery for children with tuberous sclerosis complex. J Child Neurol. 19:687-689.
78. You G, Yan W, Zhang W, Wang Y, Bao Z, Li S, Li G, Song Y, Kang C, Jiang T. 2012. Significance of miR-196b in tumor-related epilepsy of patients with gliomas. PLoS One. 7:e46218.
79. Yue D, Liu H, Huang Y. 2009. Survey of computational algorithms for microRNA target prediction. Curr Genomics. 10:478-492.
80. Zhao X, Wu J, Zheng M, Gao F, Ju G. 2012. Specification and maintenance of oligodendrocyte precursor cells from neural progenitor cells: involvement of microRNA-7a. Mol Biol Cell. 23:2867-2878.